OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 69 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $638 | -99.9% | 260,500 | 0.0% | 0.04% | +16.1% |
| Q3 2022 | $719,000 | -32.2% | 260,500 | 0.0% | 0.03% | -45.6% |
| Q2 2022 | $1,060,000 | -4.5% | 260,500 | 0.0% | 0.06% | +23.9% |
| Q1 2022 | $1,110,000 | -54.5% | 260,500 | 0.0% | 0.05% | -30.3% |
| Q4 2021 | $2,438,000 | -66.0% | 260,500 | 0.0% | 0.07% | -59.0% |
| Q3 2021 | $7,179,000 | -1.5% | 260,500 | 0.0% | 0.16% | +8.8% |
| Q2 2021 | $7,289,000 | -15.7% | 260,500 | 0.0% | 0.15% | -3.3% |
| Q1 2021 | $8,643,000 | -31.0% | 260,500 | 0.0% | 0.15% | -43.1% |
| Q4 2020 | $12,525,000 | – | 260,500 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |